Sign In
Buy PFE
$26.04
+0.345 (+1.34%)
At Close: Jun 05, 2026
Pfizer names Chris Boshoff as new R&D chief, WSJ reports
06:27am, Wednesday, 20'th Nov 2024
Pfizer has named company veteran Chris Boshoff, who led the drugmaker's cancer research and marketing for more than a year, as its R&D chief, WSJ reported on Wednesday.
Pfizer Names New R&D Chief
06:15am, Wednesday, 20'th Nov 2024
Company veteran Chris Boshoff, who has led Pfizer's cancer research and marketing for more than a year, will become chief scientific officer starting Jan. 1.
Is It Time to Sell Eli Lilly and Pfizer Stocks?
05:48am, Wednesday, 20'th Nov 2024
Is It Time to Sell Eli Lilly and Pfizer Stocks?
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has granted marketing authorization for HYMPAVZI™ (marstacimab) for the routine prophylaxis of bl
If I Could Only Buy 2 High Dividend Yield Companies In November 2024: Both Yield Above 6%
06:00pm, Tuesday, 19'th Nov 2024
I have selected Pfizer and Verizon as my top two high dividend yield companies to invest in for November 2024. Both pay an attractive Dividend Yield [FWD] of 6.14% (Pfizer) and 6.58% (Verizon) and hav
Pfizer loses bid to recoup $75 million left over from SEC settlement
05:05pm, Tuesday, 19'th Nov 2024
A federal judge on Tuesday rejected Pfizer's bid to recoup about $75.2 million left over from a U.S. Securities and Exchange Commission settlement with billionaire Steven A. Cohen's hedge fund SAC Cap
BridgeBio Pharma's Acoramidis Shows Competitive Edge Against Pfizer's Tafamidisa In Lucrative But Competitive ATTR-CM Market
02:44pm, Tuesday, 19'th Nov 2024
On Monday, BridgeBio Pharma, Inc. BBIO presented initial outcomes from the ATTRibute-CM open-label extension (OLE) study of acoramidis in ATTR-CM at the American Heart Association Scientific Session
These 4 Price-to-Sales Stocks Can Supercharge Your Portfolio Growth
08:45am, Tuesday, 19'th Nov 2024
The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like AGR, SMP, GBX and PFE hold promise.
Buy 5 U.S. Bigwigs on the Dip for Sparkling Returns in the Short Term
03:00pm, Monday, 18'th Nov 2024
Five stocks currently available at attractive valuations after sizeable corrections in prices are: PFE, NEM, UBER, ADBE, QCOM.
Medicus Pharma unveils ex-GSK and Pfizer senior as chief medical officer
12:03pm, Monday, 18'th Nov 2024
Medicus Pharma (TSX-V:MDCX, NASDAQ:MDCX) Ltd has announced the appointment of Faisal Mehmud, formerly of GSK PLC (LSE:GSK, NYSE:GSK) and Pfizer Inc (NYSE:PFE, ETR:PFE), as chief medical officer. Mehmu
2 High-Yield Dividend Stocks I Can't Stop Buying
06:45am, Monday, 18'th Nov 2024
2 High-Yield Dividend Stocks I Can't Stop Buying
As Drug Maker Stocks Fall, Pressure Builds On PhRMA To Derail RFK, Jr.
10:03pm, Friday, 15'th Nov 2024
Stocks of major drug makers and biotech companies tumbled in trading late this week after President-elect Donald Trump announced that he wants vaccine skeptic Robert F. Kennedy Jr. to lead the U.S. De
Moderna, Lily, Novavax, and Pfizer stocks fall after Trump nominates RFK Jr. as health secretary
02:31pm, Friday, 15'th Nov 2024
Shares in some of America's largest drug manufacturers tumbled yesterday after President-elect Donald Trump announced Robert F. Kennedy Jr. as his pick for secretary of the Department of Health and Hu
Stock Of The Day: Is Pfizer Set Up To Rally?
01:16pm, Friday, 15'th Nov 2024
Pfizer Inc. PFE shares are lower on Thursday due to news that President-elect Donald Trump picked Robert F. Kennedy Jr. as his next secretary of the Department of Health and Human Services.
Vaccine Maker Stocks Slump After RFK Jr. Nominated as HHS Head
12:55pm, Friday, 15'th Nov 2024
In the 2024 presidential election's latest impact on the stock markets, shares of several vaccine makers were down Friday morning following the nomination of Robert F. Kennedy Jr. to head the Departme
